Evidence map›Paper›PMID 37212071›Full record

ArticleJournal of Parkinson's disease2023

Relative Meaningfulness and Impacts of Symptoms in People with Early-Stage Parkinson's Disease.

Jennifer R Mammen, Rebecca M Speck, Glenn T Stebbins, Martijn L T M Müller, Phillip T Yang, Michelle Campbell, Josh Cosman, John E Crawford, Tien Dam, Johan Hellsten and 8 more

Abstract read
In one paragraph

Article in Journal of Parkinson's disease, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Examining the lived experience of dementia with Lewy bodies through qualitative research: A systematic review.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025
    Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Determining what matters most to patients: qualitative interview techniques and methodological considerations for concept saliency analysis and reporting.Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation · 2026
    Article
  6. Article
  7. Article
  8. Article
  9. Digital Technologies for Symptom Monitoring in Parkinson Disease.Current neurology and neuroscience reports · 2026
    Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Developing digital health technologies for frontotemporal degeneration.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025
    Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Jennifer R MammenUniversity of Rhode Island, College of Nursing, Providence, RI, USA.
Rebecca M SpeckCritical Path Institute, Tucson, AZ, USA.
Glenn T StebbinsDepartment of Neurological Sciences, Rush University Medical Center, Chicago, IL, USA.
Martijn L T M MüllerCritical Path Institute, Tucson, AZ, USA.
Phillip T YangCenter for Health + Technology, University of Rochester, Rochester, NY, USA.
Michelle CampbellCenter for Drug Evaluation and Research (CDER), U.S. Food and Drug Administration (FDA), Silver Spring, MD, USA.
Josh CosmanAbbvie Inc., North Chicago, IL, USA.
John E Crawford
Tien DamBiogen, Cambridge, MA, USA.
Johan HellstenH. Lundbeck A/S, Valby, Denmark.
Stella Jensen-RobertsCenter for Health + Technology, University of Rochester, Rochester, NY, USA.
Melissa KostrzebskiCenter for Health + Technology, University of Rochester, Rochester, NY, USA.
Tanya SimuniNorthwestern University Feinberg School of Medicine, Chicago, IL, USA.
Kimberly Ward BarowiczCritical Path Institute, Tucson, AZ, USA.
Jesse M CedarbaumCoeruleus Clinical Sciences LLC, Woodbridge, CT, USA.
E Ray DorseyCenter for Health + Technology, University of Rochester, Rochester, NY, USA.
Diane StephensonCritical Path Institute, Tucson, AZ, USA.
Jamie L AdamsCenter for Health + Technology, University of Rochester, Rochester, NY, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPatient perspectives on meaningful symptoms and impacts in early Parkinson's disease (PD) are lacking and are urgently needed to clarify priority areas for monitoring, management, and new therapies.

objectiveTo examine experiences of people with early-stage PD, systematically describe meaningful symptoms and impacts, and determine which are most bothersome or important.

methodsForty adults with early PD who participated in a study evaluating smartwatch and smartphone digital measures (WATCH-PD study) completed online interviews with symptom mapping to hierarchically delineate symptoms and impacts of disease from "Most bothersome" to "Not present," and to identify which of these were viewed as most important and why. Individual symptom maps were coded for types, frequencies, and bothersomeness of symptoms and their impacts, with thematic analysis of narratives to explore perceptions.

resultsThe three most bothersome and important symptoms were tremor, fine motor difficulties, and slow movements. Symptoms had the greatest impact on sleep, job functioning, exercise, communication, relationships, and self-concept- commonly expressed as a sense of being limited by PD. Thematically, most bothersome symptoms were those that were personally limiting with broadest negative impact on well-being and activities. However, symptoms could be important to patients even when not present or limiting (e.g., speech, cognition).

conclusionMeaningful symptoms of early PD can include symptoms that are present or anticipated future symptoms that are important to the individual. Systematic assessment of meaningful symptoms should aim to assess the extent to which symptoms are personally important, present, bothersome, and limiting.

Indexed as

Parkinson DiseaseAdultCognitionExerciseHumansHypokinesiaTremordigital health technologymeaningfulnessParkinson’s diseasequalitative

Identifiers

PMID37212071
PMCPMC10357209

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.